Ticks and tick-borne diseases (TBDs) are a growing global problem for human health. Currently, 18 tick-borne infectious pathogens, 20 conditions, and 13 illnesses are known to result from tick bites, and more continue to be identified. Check out our updated tick blog "Growing concern: tick-borne pathogens expand their reach" and uncover the need for accurate and reliable tick-borne diagnostic test methods. Read now: https://hubs.ly/Q02GbdST0 #tickbornepathogens #blogpost #moleculardiagnostics
About us
LGC Clinical Diagnostics develops and manufactures a comprehensive portfolio of catalog and custom-developed diagnostic quality solutions, biological and reagent component materials for the extended life sciences industry. Our scientific expertise, together with our custom product development capabilities, further accelerates bringing your innovations to life. Together, we are changing the future of diagnostics. LGC Clinical Diagnostics has over 35 years of experience as a leading and trusted global manufacturer of Quality Management Tools (QMT) and reagent components. We partner with In Vitro Diagnostics (IVD) and biopharmaceutical developers, clinical research organizations (CROs) and academic institutions in commercialization activities across the entire diagnostic pipeline - from concept and early-stage research, through expedited product development and onwards into routine clinical use. Laboratories and diagnostic professionals across disciplines of clinical chemistry, immunochemistry, serology, molecular diagnostics, and clinical genomics rely on LGC’s products to achieve accurate and reliable diagnostic results. Our combined and ever-growing capabilities mean we are better positioned to support the needs of the clinical diagnostics industry, from early feasibility and research to commercial & laboratory development test (LDT) assay development, installation, validation and ongoing performance monitoring support. LGC Clinical Diagnostics Quality Management and reagent component manufacturing facilities are FDA-registered, and ISO 13485 and ISO 9001-certified. Our brands include Technopath Clinical Diagnostics, SeraCare, Biochemical Diagnostics, Inc., KOVA International, Maine Standards, and The Native Antigen Company. Together, our brands serve over 7,500 customers in over 120 countries, providing products for more than 20 clinical application areas, including infectious diseases, NIPT, diabetes, cardiac disease and oncology.
- Website
-
https://lgcclinicaldiagnostics.com
External link for LGC Clinical Diagnostics
- Industry
- Biotechnology
- Company size
- 1,001-5,000 employees
- Headquarters
- Milford, Massachusetts
- Type
- Privately Held
- Specialties
- linearity and calibration verification, reference materials, antigens and antibodies, research components, biological materials, Quality Measurement Tools, Informatics, and Quality Controls
Locations
Employees at LGC Clinical Diagnostics
Updates
-
Thank you for visiting us at Booth 5 last week at AMP Europe 2024 in Madrid. The event was a great success, and it was wonderful to connect with all of you. In review, here are some informative resources for you, such as posters from previous years' AMP event: https://hubs.ly/Q02G65pq0 #AMPEurope24 #ScientificPosters
-
A groundbreaking article on NuProbe's VarTrace qPCR assay for detecting Microsatellite Instability (MSI) in cancer using a novel tumor-only approach is featured in the Clinical Chemistry journal. We're especially proud that our Seraseq MSI Reference Panel played a crucial role, demonstrating a detection limit of 5% variant allele frequency and an input limit of 0.5 ng. Discover how this advancement is transforming cancer diagnostics and clinical workflows. Read the Article: https://hubs.ly/Q02FQR3w0 #CancerResearch #MSI #ClinicalChemistry #Seraseq
Microsatellite Instability Detection in Cancer: A Multiplex qPCR Approach that Obviates the Need for Matching Normal Samples
-
LGC Clinical Diagnostics and Biosearch Technologies are attending ADLM 2024 in Chicago, IL July 28 - August 1 - come visit us at booth 2845! Learn more about our diagnostics and genomics one-stop-shop, OR schedule a meeting with one of our representatives by clicking on this link: https://hubs.ly/Q02FGKbp0 #ADLM2024
Come visit us at booth 2845 at ADLM 2024!
digital.lgcclinicaldiagnostics.com
-
The Native Antigen Company is excited to share we have expanded our Paramyxoviridae antigen portfolio to include the Hendra virus glycoprotein G, Nipah virus glycoprotein G-Bangladesh, and Nipah virus glycoprotein G- Malaysia. These glycoproteins are presented tag-free, ensuring cross-reactivity with typical purification handles such as Fc-tags is avoided in your assay design. To learn more visit each virus website page by clicking the respective link below: Hendra- https://hubs.ly/Q02Fjfwr0 Nipah- https://hubs.ly/Q02FjrDw0 #newantigens #vaccineresearch #hendravirus #nipahvirus
-
ACCURUN® Swab Reference Materials for respiratory diseases SARS-CoV-2, Flu A/B and RSV can help you achieve precise molecular PCR test results. The preferred choice for laboratories, these patient-like, low positive, ready-to-use kits offer superior performance, convenience, and safety. Click LEARN MORE below to visit our website and download the ACCURUN Swab Product Sheet: https://hubs.ly/Q02F3Tm20 #referencematerials #respiratoryinfections #accuracytesting
ACCURUN® Swab Reference Materials Product Sheet
digital.seracare.com
-
LGC Clinical Diagnostics and Biosearch Technologies are attending ADLM 2024 together and sharing booth 2845! Come visit us in Chicago, IL July 28 - August 1 to learn more about our diagnostics and genomics one-stop-shop, OR schedule a meeting with one of our representatives by clicking on this link: https://hubs.ly/Q02DLfb70 #ADLM2024
Come visit us at booth 2845 at ADLM 2024!
digital.lgcclinicaldiagnostics.com
-
We are thrilled to share the scientific posters that were standout highlights at AACR 2024 in San Diego, CA - evaluations of cell-free DNA extraction kits, DNA methylation in cell-free circulating tumor DNA, liquid biopsy reference materials, and DNA extraction for FFPE tissues. These resources are now available on our website to support your research and diagnostics journey: https://hubs.ly/Q02Drg330 #AACR2024 #LiquidBiopsy #DNAMethylation #DNAExtraction
Oncology Resources
seracare.com
-
The Native Antigen Company is pleased to announce the launch of our Recombinant Neisseria gonorrheae RmpM Antigen! This recombinant antigen, expressed in E.coli, is an ideal candidate component for vaccine components and therapeutic targets. It is of high quality and purity, facilitating research on the pivotal role of Rmp (reduction modifiable protein). This supports the development of effective vaccines and treatments to reduce the global burden of gonorrhea. To kickstart your vaccine development project click the order now button below: https://hubs.ly/Q02CSy_D0 #newantigen #vaccinedevelopment #neisseriagonorrhoeae
Neisseria Gonorrhoeae RmpM - The Native Antigen Company
-
LGC Clinical Diagnostics and Biosearch Technologies are attending ADLM 2024 together! Come visit us at booth 2845 in Chicago, IL July 28 - August 1 to learn more about our diagnostics and genomics one-stop-shop, OR schedule a meeting with one of our representatives by clicking on this link: https://hubs.ly/Q02CG3h50
Come visit us at booth 2845 at ADLM 2024!
digital.lgcclinicaldiagnostics.com